The Nation

Cassidy Questions White House Reasoning for Pulling FDA Nominee Heidi Overton

Sen. Bill Cassidy questioned the White House's reasons for pulling FDA commissioner nominee Heidi Overton, saying he thought she had the support needed to be confirmed.

The American Intelligencer standing plate
From the pages of The American Intelligencer.

Sen. Bill Cassidy (R-La.) questioned the Trump administration's reasoning for pulling its nomination of Heidi Overton to be Food and Drug Administration (FDA) commissioner, according to The Hill's report on Cassidy's criticism of the withdrawal. Cassidy said he thought Overton had the support needed to be confirmed.

The Hill's headline also describes the White House move as odd. The summary available for this story does not say whether that characterization came from Cassidy or from the outlet.

In remarks as The Hill summarized them, Cassidy said, "Tonight, the White House abandoned a viable confirmation path for Dr. Overton."

The Hill reported that the White House said the decision was because Overton did not have the support needed for confirmation. The available summary ends before the rest of that explanation, so the complete reasoning the White House gave could not be confirmed from this account.

The Hill report was written by Ford McCracken and published on November 18, 2026. No other outlet's reporting on the matter was available for this story, so Cassidy's comments and the White House explanation rest on The Hill's summary alone.

Sources: The Hill: Cassidy questions 'odd' White House move in pulling FDA nominee.